Document is current
Any future updates will be listed below
-
Authors
Tos, Salem M.
Osama, Mahmoud
Mantziaris, Georgios
Hajikarimloo, Bardia
Adeeb, Nimer
Kandregula, Sandeep
Dmytriw, Adam A.
Salim, Hamza Adel
Musmar, Basel
Naamani, Kareem El
Ogilvy, Christopher
Kondziolka, Douglas
Abdelsalam, Ahmed
Kumbhare, Deepak
Gummadi, Sanjeev
Ataoglu, Cagdas
Erginoglu, Ufuk
Essibayi, Muhammed Amir
Keles, Abdullah
Muram, Sandeep
Sconzo, Daniel
Riina, Howard
Rezai, Arwin
Pöppe, Johannes
Sen, Rajeev D.
Alwakaa, Omar
Griessenauer, Christoph J.
Jabbour, Pascal
Tjoumakaris, Stavropoula I.
Burkhardt, Jan-Karl
Starke, Robert M.
Baskaya, Mustafa
Sekhar, Laligam N.
Levitt, Michael R.
Altschul, David J.
Haranhalli, Neil
McAvoy, Malia
Aslan, Assala
Abushehab, Abdallah
Swaid, Christian
Abla, Adib
Stapleton, Christopher
Koch, Matthew
Srinivasan, Visish M.
Chen, Peng R.
Blackburn, Spiros
Dannenbaum, Mark J.
Choudhri, Omar
Pukenas, Bryan
Orbach, Darren
Smith, Edward
Möhlenbruch, Markus
Alaraj, Ali
Aziz-Sultan, Ali
Patel, Aman B.
Cuellar, Hugo H.
Lawton, Michael
Morcos, Jacques
Guthikonda, Bharat
Sheehan, Jason
- License Information
-
More Information
Article History
Received: 28 October 2024
Revised: 13 February 2025
Accepted: 20 February 2025
First Online: 28 February 2025
Declarations
:
: This retrospective multicenter clinical cohort study was conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved by the Institutional Review Board (IRB) of University of Virginia Hospital. Due to the retrospective nature of the study, the requirement for informed consent was waived by the IRB. All patient data were anonymized and de-identified prior to analysis to ensure patient confidentiality.
: The researchers reported that there was no conflict of interest
: Dr. Griessenauer reported personal fees from MicroVention and Stryker, proctoring for Medtronic, and grants from Penumbra and Baxter outside the submitted work. Dr. Tjoumakaris reported being a consultant for MicroVention. Dr. Burkhardt reported being a consultant for MicroVention, Stryker, Q’Apel, Cerenovos, and Longeviti Neuro Solutions outside the submitted work. Dr. Möhlenbruch reported grants from Balt, MicroVention, Medtronic, and Stryker outside the submitted work. A. B. Patel reported personal fees from MicroVention, Medtronic, and Penumbra outside the submitted work.Dr. Cuellar reported being a consultant for MicroVention. The rest of authors declared no personal, financial, or institutional interests related to the drugs, materials, or devices discussed in the article.
: The study was approved by institutional review boards, with waived informed consent due to its retrospective design. Data was de-identified for confidentiality.
: Not applicable.
